These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1692662)

  • 1. Effects of calcium channel modulators on the proliferation of mouse spleen lymphocytes in vitro.
    Kunert-Radek J; Stepien H; Lyson K; Pawlikowski M
    Agents Actions; 1990 Mar; 29(3-4):254-8. PubMed ID: 1692662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dihydropyridine Ca2+ channel blockers on the discriminative stimulus and the motor impairing effects of (+/-)-Bay K 8644.
    Cohen C; Perrault G; Sanger DJ
    Eur J Pharmacol; 1997 Oct; 336(2-3):113-21. PubMed ID: 9384222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-dependent calcium channels regulate GH4 pituitary cell proliferation at two stages of the cell cycle.
    Ramsdell JS
    J Cell Physiol; 1991 Feb; 146(2):197-206. PubMed ID: 1705563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dihydropyridine calcium channel modulators on pentylenetetrazole convulsions.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1990 Jul; 25(1):211-4. PubMed ID: 1698518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of calcium channel blockers on human mesangial cell growth: evidence for actions independent of L-type Ca2+ channels.
    Orth SR; Nobiling R; Bönisch S; Ritz E
    Kidney Int; 1996 Mar; 49(3):868-79. PubMed ID: 8648932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ca2+ channel agonists enhance thyrotropin-releasing hormone-induced inositol phosphates and prolactin secretion.
    Pachter JA; Law GJ; Dannies PS
    Eur J Pharmacol; 1991 Apr; 195(3):373-9. PubMed ID: 1714395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of calcium channel blockers on proliferation of human glioma cells in vitro.
    Kunert-Radek J; Stepien H; Radek A; Lyson K; Pawlikowski M
    Acta Neurol Scand; 1989 Feb; 79(2):166-9. PubMed ID: 2711824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells.
    Lijnen P; Fagard R; Petrov V
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):595-604. PubMed ID: 10218730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological dissection of Ca2+ channels in the rat aorta by Ca2+ entry modulators.
    Rico I; Alonso MJ; Salaices M; Marín J
    Pharmacology; 1990; 40(6):330-42. PubMed ID: 1700444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel calcium channel agonist dihydropyridine analogue, Bay k 8644, on pig coronary artery: biphasic mechanical response and paradoxical potentiation of contraction by diltiazem and nimodipine.
    Dubé GP; Baik YH; Schwartz A
    J Cardiovasc Pharmacol; 1985; 7(2):377-89. PubMed ID: 2581094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Ca agonists Bay K 8644 and CGP 28392 on vascular smooth muscle tone.
    Alonso MJ; Rico I; Salaices M; Marin J
    Gen Pharmacol; 1989; 20(6):827-31. PubMed ID: 2480266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of calcium channel agonists (BAY K 8644, CGP28392 and YC-170) on 45Ca uptake by rat uterine segments.
    Ichida S; Ariyoshi S; Fujisue T; Wada T; Akimoto T
    Jpn J Pharmacol; 1991 Aug; 56(4):397-402. PubMed ID: 1720823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine calcium agonists selectively enhance resistance artery myogenic tone.
    Hwa JJ; Bevan JA
    Eur J Pharmacol; 1986 Jul; 126(3):231-8. PubMed ID: 2428633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.
    Szabó C; Thiemermann C; Vane JR
    Biochem Biophys Res Commun; 1993 Oct; 196(2):825-30. PubMed ID: 7694580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses, calcium channel agonist-antagonist modulation activities, and voltage-clamp studies of isopropyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-pyridinylpyridine-5-carboxylate racemates and enantiomers.
    Vo D; Matowe WC; Ramesh M; Iqbal N; Wolowyk MW; Howlett SE; Knaus EE
    J Med Chem; 1995 Jul; 38(15):2851-9. PubMed ID: 7543577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidystonic effects of L-type Ca2+ channel antagonists in a hamster model of idiopathic dystonia.
    Richter A; Löscher W
    Eur J Pharmacol; 1996 Apr; 300(3):197-202. PubMed ID: 8739208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium antagonistic properties of the sesquiterpene T-cadinol: a comparison with nimodipine in the isolated rat aorta.
    Claeson P; Zygmunt P; Högestätt ED
    Pharmacol Toxicol; 1991 Sep; 69(3):173-7. PubMed ID: 1724563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyrotropin (TSH)-releasing hormone stimulates TSH beta promoter activity by two distinct mechanisms involving calcium influx through L type Ca2+ channels and protein kinase C.
    Shupnik MA; Weck J; Hinkle PM
    Mol Endocrinol; 1996 Jan; 10(1):90-9. PubMed ID: 8838148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective antagonism of calcium channel activators by fluspirilene.
    Kenny BA; Fraser S; Kilpatrick AT; Spedding M
    Br J Pharmacol; 1990 Jun; 100(2):211-6. PubMed ID: 1696149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK; McKay DW; Campbell N; Triggle CR; Crowley M; Bolger GT
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.